← Back to VPO News
📊 Blog

Experts Gather in Nihonbashi to Drive Social Implementation of Next-Generation Assessment Methodology NAMs

#一般社団法人Japan Pharmaceutical & BioScience Society #AI #Tech Release #New Tech
VENTURE PITCH ONLINE
2026/10/20
Cover
📄 Table of Contents

Event Overview

The Japan Pharmaceutical & BioScience Society (Japan PBSS) has announced that it will hold its 5th in-person event focusing on "NAMs (New Approach Methodologies)," next-generation assessment methods for pharmaceutical R&D, on Saturday, December 5, 2026, at the Nihonbashi Life Science Hub. The event will be held in a hybrid format, offering both in-person attendance and online participation.

Speakers and Program

Titled "New Approach Methodologies: From Development to Utilization, Regulatory Acceptance, and Commercialization," the event will feature experts from various fields presenting on the following topics:

Significance of NAMs (New Approach Methodologies)

NAMs are garnering significant attention as technologies that achieve both the advancement of drug discovery and development, and the replacement of animal testing. Overseas regulatory agencies such as the FDA and EMA are currently promoting their use, and in Japan as well, infrastructure development is underway through industry-academia-government collaboration centered around the PMDA. This event will serve as a platform to multidimensionally share current statuses and challenges regarding these methods.

Future Outlook

As a professional community in the pharmaceutical and bioscience sectors, Japan PBSS promotes knowledge exchange across diverse domains, ranging from R&D and regulatory affairs to business development. Through this event, the society aims to further accelerate industry-academia-government collaboration toward the practical application and societal implementation of NAMs.

Share This